Biodlink
China · $102.0M raised
- Business Model
- B2B
- Website
- biodlink.com
- Total Funding
- $102.0M
- Last Round
- $102.0M Series BJan 2018
- Rounds
- 1
About
Biologics developer & CDMO
Summary
Biodlink is a Biotech company based in China. It has raised $102.0M in total across 1 round, most recently a $102.0M Series B round in Jan 2018. Investors include Chengwei Ventures.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2018
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company